Statistics for Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria

Total visits

views
Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria 171

Total visits per month

views
December 2024 0
January 2025 0
February 2025 1
March 2025 0
April 2025 0
May 2025 0
June 2025 0

File Visits

views
curto-bjd-omal.pdf(legacy) 350
curto-bjd-omal.pdf 52

Top country views

views
United States 113
Spain 22
Germany 15
France 3
United Kingdom 3
Belgium 2
Switzerland 2
China 2
Japan 2
Sweden 2
Ukraine 2
Canada 1
Czechia 1
Denmark 1

Top city views

views
Ashburn 23
San Ramon 17
Fairfield 14
Barcelona 9
Cambridge 5
Mountain View 5
Menlo Park 4
Seattle 4
New York 3
San Diego 3
Tustin 3
Boardman 2
Frankfurt Am Main 2
Madrid 2
Shenzhen 2
Altadena 1
Basel 1
Brooklyn 1
Copenhagen 1
Coslada 1
Falls Church 1
Gatineau 1
Hamburg 1
Jacksonville 1
Magdeburg 1
Premiá De Mar 1
Redwood City 1
Rochester 1
Sacramento 1
Saint Albans 1
Salamanca 1
Santa Perpetua 1
Tokyo 1
Trazo 1